Vitamin D and the epigenome

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  Fetahu, Irfete S ^a   Höbaus, Julia ^a   Kállay, Eniko ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

1,25 dihydroxyvitamin D3; CpG island; CYP24A1; CYP27B1; DNA methylation; Histone modifications; VDR; VDRE

Indexed keywords

25 HYDROXYERGOCALCIFEROL; CALCIDIOL 1 MONOOXYGENASE; DNA; DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; SECALCIFEROL; VITAMIN D; VITAMIN D RECEPTOR;

CPG ISLAND; CYP24A1 GENE; CYP27B1 GENE; CYP2R1 GENE; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; GENE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; NONHUMAN; PROMOTER REGION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW;

EID: 84901014703     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00164     Document Type: Review

References (159)

1. Abedin, S. A., Banwell, C. M., Colston, K. W., Carlberg, C., and Campbell, M. J. (2006). Epigenetic corruption of VDR signalling in malignancy. Anticancer Res. 26, 2557-2566.
2. 3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28, 1877-1884. doi: 10.1093/carcin/bgm094
3. Andraos, C., Koorsen, G., Knight, J. C., and Bornman, L. (2011). Vitamin D receptor gene methylation is associated with ethnicity, tuberculosis, and TaqI polymorphism. Hum. Immunol. 72, 262-268. doi: 10.1016/j.humimm.2010.12.010
4. Arasaradnam, R. P., Commane, D. M., Bradburn, D., and Mathers, J. C. (2008). A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 3, 193-198. doi: 10.4161/epi.3.4.6508
5. Ballestar, E., and Esteller, M. (2005). Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger. Biochem. Cell Biol. 83, 374-384. doi: 10.1139/o05-035
6. Barreto, G., Schafer, A., Marhold, J., Stach, D., Swaminathan, S. K., Handa, V., et al. (2007). Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445, 671-675. doi: 10.1038/nature05515
7. Baylin, S. B., and Jones, P. A. (2011). A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 11, 726-734. doi: 10.1038/nrc3130
8. Bestor, T. H. (2005). Transposons reanimated in mice. Cell 122, 322-325. doi: 10.1016/j.cell.2005.07.024
9. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. doi: 10.1101/gad.947102
10. Bird, A. P. (1980). DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res. 8, 1499-1504. doi: 10.1093/nar/8.7.1499
11. Bjornsson, H. T., Brown, L. J., Fallin, M. D., Rongione, M. A., Bibikova, M., Wickham, E., et al. (2007). Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J. Natl. Cancer Inst. 99, 1270-1273. doi: 10.1093/jnci/djm069
12. Bouillon, R., Carmeliet, G., Verlinden, L., Van Etten, E., Verstuyf, A., Luderer, H. F., et al. (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776. doi: 10.1210/er.2008-0004
13. Bremmer, F., Thelen, P., Pottek, T., Behnes, C. L., Radzun, H. J., and Schweyer, S. (2012). Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis. Anticancer Res. 32, 341-349.
14. Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., et al. (2008). DNA methylation markers and early recurrence in stage I lung cancer. N. Engl. J. Med. 358, 1118-1128. doi: 10.1056/NEJMoa0706550
15. Carling, T., Rastad, J., Szabó, E., Westin, G., and Akerström, G. (2000). Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85, 2000-2003. doi: 10.1210/jc.85.5.2000
16. Chandel, N., Husain, M., Goel, H., Salhan, D., Lan, X., Malhotra, A., et al. (2013). VDR hypermethylation and HIV-induced T cell loss. J. Leukoc. Biol. 93, 623-631. doi: 10.1189/jlb.0812383
17. Choi, J. H., Kwon, H. J., Yoon, B. I., Kim, J. H., Han, S. U., Joo, H. J., et al. (2001). Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn. J. Cancer Res. 92, 1300-1304. doi: 10.1111/j.1349-7006.2001.tb02153.x
18. Christensen, J., Agger, K., Cloos, P. A., Pasini, D., Rose, S., Sennels, L., et al. (2007). RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128, 1063-1076. doi: 10.1016/j.cell.2007.02.003
19. Cloos, P. A., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., et al. (2006). The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442, 307-311. doi: 10.1038/nature04837
20. Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., et al. (2003). Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753-1755. doi: 10.1126/science.1080902
21. Ding, J., Zhang, Z. M., Xia, Y., Liao, G. Q., Pan, Y., Liu, S., et al. (2013). LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer. Br. J. Cancer 109, 994-1003. doi: 10.1038/bjc.2013.364
22. Doig, C. L., Singh, P. K., Dhiman, V. K., Thorne, J. L., Battaglia, S., Sobolewski, M., et al. (2013). Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis 34, 248-256. doi: 10.1093/carcin/bgs331
23. Eden, A., Gaudet, F., Waghmare, A., and Jaenisch, R. (2003). Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455. doi: 10.1126/science.1083557
24. Esteller, M. (2007a). Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16, Spec No 1, R50-R59. doi: 10.1093/hmg/ddm018
25. Esteller, M. (2007b). Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br. J. Cancer 96(Suppl.), R26-R30. doi: 10.1038/sj.bjc.6602918
26. Esteller, M. (2008). Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159. doi: 10.1056/NEJMra072067
27. Esteller, M., Catasus, L., Matias-Guiu, X., Mutter, G. L., Prat, J., Baylin, S. B., et al. (1999). hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am. J. Pathol. 155, 1767-1772. doi: 10.1016/S0002-9440(10)65492-2
28. Feinberg, A. P., Cui, H., and Ohlsson, R. (2002). DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin. Cancer Biol. 12, 389-398. doi: 10.1016/S1044-579X(02)00059-7
29. Ficz, G., Branco, M. R., Seisenberger, S., Santos, F., Krueger, F., Hore, T. A., et al. (2011). Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402. doi: 10.1038/nature10008
30. Flicek, P., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., et al. (2014). Ensembl 2014. Nucleic Acids Res. 42, D749-D755. doi: 10.1093/nar/gkt1196
31. Fodor, B. D., Kubicek, S., Yonezawa, M., O'Sullivan, R. J., Sengupta, R., Perez-Burgos, L., et al. (2006). Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20, 1557-1562. doi: 10.1101/gad.388206
32. Frescas, D., Guardavaccaro, D., Bassermann, F., Koyama-Nasu, R., and Pagano, M. (2007). JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450, 309-313. doi: 10.1038/nature06255
33. Frescas, D., Guardavaccaro, D., Kuchay, S. M., Kato, H., Poleshko, A., Basrur, V., et al. (2008). KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state. Cell Cycle 7, 3539-3547. doi: 10.4161/cc.7.22.7062
34. 3 through DNA methylation and histone modification. PLoS ONE 8:e61423. doi: 10.1371/journal.pone.0061423
35. Garcia-Bassets, I., Kwon, Y. S., Telese, F., Prefontaine, G. G., Hutt, K. R., Cheng, C. S., et al. (2007). Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518. doi: 10.1016/j.cell.2006.12.038
36. Gardiner-Garden, M., and Frommer, M. (1987). CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261-282. doi: 10.1016/0022-2836(87)90689-9
37. Gaschott, T., and Stein, J. (2003). Short-chain fatty acids and colon cancer cells: the vitamin D receptor-butyrate connection. Recent Results Cancer Res. 164, 247-257. doi: 10.1007/978-3-642-55580-0_18
38. Godman, C. A., Joshi, R., Tierney, B. R., Greenspan, E., Rasmussen, T. P., Wang, H. W., et al. (2008). HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol. Ther. 7, 1570-1580. doi: 10.4161/cbt.7.10.6561
39. Gogusev, J., Duchambon, P., Hory, B., Giovannini, M., Goureau, Y., Sarfati, E., et al. (1997). Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 51, 328-336. doi: 10.1038/ki.1997.41
40. Greer, E. L., and Shi, Y. (2012). Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357. doi: 10.1038/nrg3173
41. Greger, V., Passarge, E., Höpping, W., Messmer, E., and Horsthemke, B. (1989). Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155-158. doi: 10.1007/BF00286709
42. Gruenbaum, Y., Stein, R., Cedar, H., and Razin, A. (1981). Methylation of CpG sequences in eukaryotic DNA. FEBS Lett. 124, 67-71. doi: 10.1016/0014-5793(81)80055-5
43. Guarente, L. (2006). Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874. doi: 10.1038/nature05486
44. Habano, W., Gamo, T., Terashima, J., Sugai, T., Otsuka, K., Wakabayashi, G., et al. (2011). Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells. BMC Cancer 11:81. doi: 10.1186/1471-2407-11-81
45. Haberland, M., Montgomery, R. L., and Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42. doi: 10.1038/nrg2485
46. Hackett, J. A., Sengupta, R., Zylicz, J. J., Murakami, K., Lee, C., Down, T. A., et al. (2013). Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 339, 448-452. doi: 10.1126/science.1229277
47. Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., and Robson, C. N. (2004). Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177-189. doi: 10.1002/pros.20022
48. Halsall, J. A., Osborne, J. E., Hutchinson, P. E., and Pringle, J. H. (2007). In silico analysis of the 5' region of the Vitamin D receptor gene: functional implications of evolutionary conservation. J. Steroid. Biochem. Mol. Biol. 103, 352-356. doi: 10.1016/j.jsbmb.2006.12.046
49. Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J. C., et al. (2013). Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77-98. doi: 10.1007/s00223-012-9619-0
50. Hebbes, T. R., Thorne, A. W., and Crane-Robinson, C. (1988). A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7, 1395-1402.
51. Helin, K., and Dhanak, D. (2013). Chromatin proteins and modifications as drug targets. Nature 502, 480-488. doi: 10.1038/nature12751
52. Hendrix, I., Anderson, P., May, B., and Morris, H. (2004). Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model. J. Steroid Biochem. Mol. Biol. 89-90, 139-142. doi: 10.1016/j.jsbmb.2004.03.093
53. Herman, J. G., and Baylin, S. B. (2003). Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054. doi: 10.1056/NEJMra023075
54. 3 24-hydroxylase (CYP24A1) in colon cancer cells. J. Steroid Biochem. Mol. Biol. 136, 296-299. doi: 10.1016/j.jsbmb.2012.08.003
55. Höbaus, J., Hummel, D. M., Thiem, U., Fetahu, I. S., Aggarwal, A., Müllauer, L., et al. (2013b). Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer. Int. J. Cancer 133, 1380-1388. doi: 10.1002/ijc.28143
56. Hobaus, J., Thiem, U., Hummel, D. M., and Kallay, E. (2013). Role of calcium, vitamin d, and the extrarenal vitamin d hydroxylases in carcinogenesis. Anticancer Agents Med. Chem. 13, 20-35. doi: 10.2174/187152013804487434
57. Hofman-Bang, J., Gravesen, E., Olgaard, K., and Lewin, E. (2012). Epigenetic methylation of parathyroid CaR and VDR promoters in experimental secondary hyperparathyroidism. Int. J. Nephrol. 2012:123576. doi: 10.1155/2012/123576
58. Iwase, S., Lan, F., Bayliss, P., De La Torre-Ubieta, L., Huarte, M., Qi, H. H., et al. (2007). The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088. doi: 10.1016/j.cell.2007.02.017
59. 3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem. 278, 48030-48040. doi: 10.1074/jbc.M308430200
60. Jin, B., and Robertson, K. D. (2013). DNA methyltransferases, DNA damage repair, and cancer. Adv. Exp. Med. Biol. 754, 3-29. doi: 10.1007/978-1-4419-9967-2_1
61. Johnson, C. S., Chung, I., and Trump, D. L. (2010). Epigenetic silencing of CYP24 in the tumor microenvironment. J. Steroid Biochem. Mol. Biol. 121, 338-342. doi: 10.1016/j.jsbmb.2010.03.046
62. Jones, P. A., and Baylin, S. B. (2007). The epigenomics of cancer. Cell 128, 683-692. doi: 10.1016/j.cell.2007.01.029
63. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., et al. (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19, 187-191. doi: 10.1038/561
64. Jung-Hynes, B., Reiter, R. J., and Ahmad, N. (2010). Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J. Pineal Res. 48, 9-19. doi: 10.1111/j.1600-079X.2009.00729.x
65. Kahl, P., Gullotti, L., Heukamp, L. C., Wolf, S., Friedrichs, N., Vorreuther, R., et al. (2006). Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 66, 11341-11347. doi: 10.1158/0008-5472.CAN-06-1570
66. Karlic, H., and Varga, F. (2011). Impact of vitamin D metabolism on clinical epigenetics. Clin. Epigenetics 2, 55-61. doi: 10.1007/s13148-011-0021-y
67. Karolchik, D., Barber, G. P., Casper, J., Clawson, H., Cline, M. S., Diekhans, M., et al. (2014). The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 42, D764-770. doi: 10.1093/nar/gkt1168
68. 3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron. Proc. Natl. Acad. Sci. U.S.A. 78, 1199-1203. doi: 10.1073/pnas.78.2.1199
69. Khorchide, M., Lechner, D., and Cross, H. S. (2005). Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells. J. Steroid Biochem. Mol. Biol. 93, 167-172. doi: 10.1016/j.jsbmb.2004.12.022
70. Kim, G. D., Ni, J., Kelesoglu, N., Roberts, R. J., and Pradhan, S. (2002). Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21, 4183-4195. doi: 10.1093/emboj/cdf401
71. Kim, M. S., Fujiki, R., Kitagawa, H., and Kato, S. (2007a). 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol. Cell Endocrinol. 265-266, 168-173. doi: 10.1016/j.mce.2006.12.014
72. Kim, M. S., Fujiki, R., Murayama, A., Kitagawa, H., Yamaoka, K., Yamamoto, Y., et al. (2007b). 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol. Endocrinol. 21, 334-342. doi: 10.1210/me.2006-0231
73. Kim, S., Li, M., Paik, H., Nephew, K., Shi, H., Kramer, R., et al. (2008). Predicting DNA methylation susceptibility using CpG flanking sequences. Pac. Symp. Biocomput. 13, 315-326.
74. Klose, R. J., Yamane, K., Bae, Y., Zhang, D., Erdjument-Bromage, H., Tempst, P., et al. (2006). The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442, 312-316. doi: 10.1038/nature04853
75. Klose, R. J., Yan, Q., Tothova, Z., Yamane, K., Erdjument-Bromage, H., Tempst, P., et al. (2007). The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128, 889-900. doi: 10.1016/j.cell.2007.02.013
76. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705. doi: 10.1016/j.cell.2007.02.005
77. Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930. doi: 10.1126/science.1169786
78. Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., et al. (2003). The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell Biol. 23, 2669-2679. doi: 10.1128/MCB.23.8.2669-2679.2003
79. Lee, J. W., Lee, Y. C., Na, S. Y., Jung, D. J., and Lee, S. K. (2001). Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol. Life Sci. 58, 289-297. doi: 10.1007/PL00000856
80. Lewin, E., Garfia, B., Recio, F. L., Rodriguez, M., and Olgaard, K. (2002). Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J. Am. Soc. Nephrol. 13, 2110-2116. doi: 10.1097/01.ASN.0000024439.38838.03
81. Liau, J. Y., Liao, S. L., Hsiao, C. H., Lin, M. C., Chang, H. C., and Kuo, K. T. (2014). Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Hum Pathol. 45, 533-539. doi: 10.1016/j.humpath.2013.10.019
82. Lin, C. H., Li, B., Swanson, S., Zhang, Y., Florens, L., Washburn, M. P., et al. (2008). Heterochromatin protein 1a stimulates histone H3 lysine 36 demethylation by the Drosophila KDM4A demethylase. Mol. Cell 32, 696-706. doi: 10.1016/j.molcel.2008.11.008
83. Lin, Y. W., Ren, L. L., Xiong, H., Du, W., Yu, Y. N., Sun, T. T., et al. (2013). Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. J. Pathol. 230, 277-290. doi: 10.1002/path.4179
84. Longo, V. D., and Kennedy, B. K. (2006). Sirtuins in aging and age-related disease. Cell 126, 257-268. doi: 10.1016/j.cell.2006.07.002
85. 3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res. 32, 249-257.
86. Lu, P. J., Sundquist, K., Baeckstrom, D., Poulsom, R., Hanby, A., Meier-Ewert, S., et al. (1999). A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274, 15633-15645. doi: 10.1074/jbc.274.22.15633
87. Luo, W., Karpf, A. R., Deeb, K. K., Muindi, J. R., Morrison, C. D., Johnson, C. S., et al. (2010). Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Res. 70, 5953-5962. doi: 10.1158/0008-5472.CAN-10-0617
88. Marik, R., Fackler, M., Gabrielson, E., Zeiger, M. A., Sukumar, S., Stearns, V., et al. (2010). DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol. Ther. 10, 44-53. doi: 10.4161/cbt.10.1.11994
89. Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., and Kelly, W. K. (2001). Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1, 194-202. doi: 10.1038/35106079
90. Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766-770. doi: 10.1038/nature07107
91. Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H., et al. (2005). LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436-439. doi: 10.1038/nature04020
92. 3 induced histone profiles guide discovery of VDR action sites. J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.09.005. [Epub ahead of print].
93. 3 receptor in bone, lung, and other cancers. Mol. Carcinog. 19, 254-257. doi: 10.1002/(SICI)1098-2744(199708)19:4<254::AID-MC6>3.0.CO;2-C
94. Mosammaparast, N., and Shi, Y. (2010). Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155-179. doi: 10.1146/annurev.biochem.78.070907.103946
95. Mottet, D., Pirotte, S., Lamour, V., Hagedorn, M., Javerzat, S., Bikfalvi, A., et al. (2009). HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28, 243-256. doi: 10.1038/onc.2008.371
96. Murayama, A., Kim, M. S., Yanagisawa, J., Takeyama, K., and Kato, S. (2004). Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23, 1598-1608. doi: 10.1038/sj.emboj.7600157
97. Nagpal, S., Na, S., and Rathnachalam, R. (2005). Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 26, 662-687. doi: 10.1210/er.2004-0002
98. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389. doi: 10.1038/30764
99. Norman, A. W., and Bouillon, R. (2010). Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med. (Maywood) 235, 1034-1045. doi: 10.1258/ebm.2010.010014
100. Novakovic, B., Sibson, M., Ng, H. K., Manuelpillai, U., Rakyan, V., Down, T., et al. (2009). Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J. Biol. Chem. 284, 14838-14848. doi: 10.1074/jbc.M809542200
101. Ohyama, Y., Kusada, T., Yamasaki, T., and Ide, H. (2002). Extensive methylation of CpG island of CYP24 gene in osteoblastic ROS17/2.8 cells. Nucleic Acids Res. Suppl. 249-250. doi: 10.1093/nass/2.1.249
102. Okano, M., Bell, D. W., Haber, D. A., and Li, E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257. doi: 10.1016/S0092-8674(00)81656-6
103. Okano, M., Xie, S., and Li, E. (1998). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19, 219-220. doi: 10.1038/890
104. Padi, S. K., Zhang, Q., Rustum, Y. M., Morrison, C., and Guo, B. (2013). MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145, 437-446. doi: 10.1053/j.gastro.2013.04.012
105. Pan, L., Matloob, A. F., Du, J., Pan, H., Dong, Z., Zhao, J., et al. (2010). Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. FEBS J. 277, 989-999. doi: 10.1111/j.1742-4658.2009.07542.x
106. Parbin, S., Kar, S., Shilpi, A., Sengupta, D., Deb, M., Rath, S. K., et al. (2014). Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer. J. Histochem. Cytochem. 62, 11-33. doi: 10.1369/0022155413506582
107. 3-24-hydroxylase in rat kidney mitochondria. J. Biol. Chem. 258, 742-746.
108. Pedersen, M. T., and Helin, K. (2010). Histone demethylases in development and disease. Trends Cell Biol. 20, 662-671. doi: 10.1016/j.tcb.2010.08.011
109. Pendas-Franco, N., Aguilera, O., Pereira, F., Gonzalez-Sancho, J. M., and Munoz, A. (2008). Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res. 28, 2613-2623.
110. Pereira, F., Barbachano, A., Silva, J., Bonilla, F., Campbell, M. J., Munoz, A., et al. (2011). KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum. Mol. Genet. 20, 4655-4665. doi: 10.1093/hmg/ddr399
111. Pereira, F., Barbachano, A., Singh, P. K., Campbell, M. J., Munoz, A., and Larriba, M. J. (2012). Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 11, 1081-1089. doi: 10.4161/cc.11.6.19508
112. Perillo, B., Ombra, M. N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., et al. (2008). DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319, 202-206. doi: 10.1126/science.1147674
113. Pfau, R., Tzatsos, A., Kampranis, S. C., Serebrennikova, O. B., Bear, S. E., and Tsichlis, P. N. (2008). Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc. Natl. Acad. Sci. U.SA. 105, 1907-1912. doi: 10.1073/pnas.0711865105
114. Pike, J. W., and Meyer, M. B. (2013). Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.11.004. [Epub ahead of print].
115. Pike, J. W., Meyer, M. B., and Bishop, K. A. (2012). Regulation of target gene expression by the vitamin D receptor - an update on mechanisms. Rev. Endocr. Metab. Disord. 13, 45-55. doi: 10.1007/s11154-011-9198-9
116. Polly, P., Herdick, M., Moehren, U., Baniahmad, A., Heinzel, T., and Carlberg, C. (2000). VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 14, 1455-1463. doi: 10.1096/fj.14.10.1455
117. Rashid, S. F., Moore, J. S., Walker, E., Driver, P. M., Engel, J., Edwards, C. E., et al. (2001). Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 20, 1860-1872. doi: 10.1038/sj.onc.1204269
118. Rawson, J. B., Sun, Z., Dicks, E., Daftary, D., Parfrey, P. S., Green, R. C., et al. (2012). Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients. Nutr. Cancer 64, 919-928. doi: 10.1080/01635581.2012.711418
119. Reik, W., and Lewis, A. (2005). Co-evolution of X-chromosome inactivation and imprinting in mammals. Nat. Rev. Genet. 6, 403-410. doi: 10.1038/nrg1602
120. Rhee, I., Bachman, K. E., Park, B. H., Jair, K. W., Yen, R. W., Schuebel, K. E., et al. (2002). DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556. doi: 10.1038/416552a
121. Rhee, I., Jair, K. W., Yen, R. W., Lengauer, C., Herman, J. G., Kinzler, K. W., et al. (2000). CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003-1007. doi: 10.1038/35010000
122. Robertson, K. D. (2005). DNA methylation and human disease. Nat. Rev. Genet. 6, 597-610. doi: 10.1038/nrg1655
123. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., et al. (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443. doi: 10.1016/j.ccr.2006.04.020
124. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. (1991). Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48, 880-888.
125. 3 catalyzed by human CYP24. Eur. J. Biochem. 267, 6158-6165. doi: 10.1046/j.1432-1327.2000.01680.x
126. 3. J. Biol. Chem. 284, 8073-8082. doi: 10.1074/jbc.M808090200
127. Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., et al. (2009). Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 69, 2065-2071. doi: 10.1158/0008-5472.CAN-08-1735
128. Schwer, B., and Verdin, E. (2008). Conserved metabolic regulatory functions of sirtuins. Cell Metab. 7, 104-112. doi: 10.1016/j.cmet.2007.11.006
129. 3-dependent chromatin accessibility of early vitamin D receptor target genes. Biochim. Biophys. Acta 1829, 1266-1275. doi: 10.1016/j.bbagrm.2013.10.003
130. Shi, H., Guo, J., Duff, D. J., Rahmatpanah, F., Chitima-Matsiga, R., Al-Kuhlani, M., et al. (2007). Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. Carcinogenesis 28, 60-70. doi: 10.1093/carcin/bgl092
131. Shi, H., Yan, P. S., Chen, C. M., Rahmatpanah, F., Lofton-Day, C., Caldwell, C. W., et al. (2002). Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res. 62, 3214-3220.
132. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., et al. (2004). Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941-953. doi: 10.1016/j.cell.2004.12.012
133. Shi, Y., and Whetstine, J. R. (2007). Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25, 1-14. doi: 10.1016/j.molcel.2006.12.010
134. Singh, P. K., Doig, C. L., Dhiman, V. K., Turner, B. M., Smiraglia, D. J., and Campbell, M. J. (2013). Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 136, 258-263. doi: 10.1016/j.jsbmb.2012.10.002
135. Sulaiman, L., Juhlin, C. C., Nilsson, I. L., Fotouhi, O., Larsson, C., and Hashemi, J. (2013). Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics 8, 646-655. doi: 10.4161/epi.24823
136. Tahiliani, M., Mei, P., Fang, R., Leonor, T., Rutenberg, M., Shimizu, F., et al. (2007). The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447, 601-605. doi: 10.1038/nature05823
137. 3. Biosci. Biotechnol. Biochem. 75, 208-213. doi: 10.1271/bbb.100684
138. Tan, J., Lu, J., Huang, W., Dong, Z., Kong, C., Li, L., et al. (2009). Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation. PLoS ONE 4:e6792. doi: 10.1371/journal.pone.0006792
139. Tapp, H. S., Commane, D. M., Bradburn, D. M., Arasaradnam, R., Mathers, J. C., Johnson, I. T., et al. (2013). Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa. Aging Cell 12, 148-155. doi: 10.1111/acel.12030
140. Ting, A. H., McGarvey, K. M., and Baylin, S. B. (2006). The cancer epigenome-components and functional correlates. Genes Dev. 20, 3215-3231. doi: 10.1101/gad.1464906
141. Tsai, H. C., and Baylin, S. B. (2011). Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 21, 502-517. doi: 10.1038/cr.2011.24
142. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., et al. (2006). Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811-816. doi: 10.1038/nature04433
143. Vanoirbeek, E., Eelen, G., Verlinden, L., Carmeliet, G., Mathieu, C., Bouillon, R., et al. (2014). PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D. Oncogene 33, 1904-1911. doi: 10.1038/onc.2013.123
144. Varshney, S., Bhadada, S. K., Sachdeva, N., Arya, A. K., Saikia, U. N., Behera, A., et al. (2013). Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas. J. Clin. Endocrinol. Metab. 98, E1631-E1635. doi: 10.1210/jc.2013-1699
145. Von Essen, M. R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., and Geisler, C. (2010). Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat. Immunol. 11, 344-349. doi: 10.1038/ni.1851
146. Wang, Y., and Leung, F. C. (2004). An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 20, 1170-1177. doi: 10.1093/bioinformatics/bth059
147. Whetstine, J. R., Nottke, A., Lan, F., Huarte, M., Smolikov, S., Chen, Z., et al. (2006). Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125, 467-481. doi: 10.1016/j.cell.2006.03.028
148. Williams, K., Christensen, J., Pedersen, M. T., Johansen, J. V., Cloos, P. A., Rappsilber, J., et al. (2011). TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343-348. doi: 10.1038/nature10066
149. Wilson, A. J., Byun, D. S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., et al. (2006). Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281, 13548-13558. doi: 10.1074/jbc.M510023200
150. Wjst, M., Heimbeck, I., Kutschke, D., and Pukelsheim, K. (2010). Epigenetic regulation of vitamin D converting enzymes. J. Steroid Biochem. Mol. Biol. 121, 80-83. doi: 10.1016/j.jsbmb.2010.03.056
151. Xiang, Y., Zhu, Z., Han, G., Ye, X., Xu, B., Peng, Z., et al. (2007). JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 104, 19226-19231. doi: 10.1073/pnas.0700735104
152. Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep, D., et al. (2012). Tet1 controls meiosis by regulating meiotic gene expression. Nature 492, 443-447. doi: 10.1038/nature11709
153. Yamane, K., Tateishi, K., Klose, R. J., Fang, J., Fabrizio, L. A., Erdjument-Bromage, H., et al. (2007). PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25, 801-812. doi: 10.1016/j.molcel.2007.03.001
154. Yamshchikov, A. V., Desai, N. S., Blumberg, H. M., Ziegler, T. R., and Tangpricha, V. (2009). Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pract. 15, 438-449. doi: 10.4158/EP09101.ORR
155. 3 (1,25(OH)2D3) on neoplastic and osteoblastic phenotype in clonal rat osteosarcoma cells. Biochem. Biophys. Res. Commun. 121, 796-801. doi: 10.1016/0006-291X(84)90748-4
156. Zhang, X., Nicosia, S. V., and Bai, W. (2006). Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr. Cancer Drug. Targets 6, 229-244. doi: 10.2174/156800906776842939
157. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., et al. (2005). Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*. Breast Cancer Res. Treat. 94, 11-16. doi: 10.1007/s10549-005-6001-1
158. Zhu, H., Wang, X., Shi, H., Su, S., Harshfield, G. A., Gutin, B., et al. (2013). A genome-wide methylation study of severe vitamin D deficiency in African American adolescents. J. Pediatr. 162, 1004-1009.e1001. doi: 10.1016/j.jpeds.2012.10.059
159. Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K. P., and Göttlicher, M. (2004). Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455-463. doi: 10.1016/S1535-6108(04)00114-X